Fudan University, BS
American Indiana University, Master in Biochemistry
Purdue University, Pharm.D
18 years experience of domestic and foreign drug companies and FDA
Chief Scientist in Livzon, responsible for the chemical R&D and the distribution of biopharmaceutical
FDA Senior Director for R&D of Drug, responsible for regulatory drug development and post-marketing investigation
Novartis and Pfizer, director of the Novartis Clinical Phase Program, core member of Scientific and Technological Committee,
Standing Committee member of Chinese Society of Clinical Oncology (CSCO) special committee of Translational Medicine
Led and participated in 32 clinical stages of innovative drug R&D and declaration, of which 9 innovative drugs listed in Europe and the United States, such as Signifor® LAR, Valturna®, EntrestoTM, Diovan®, Torisel®
Published more than 80 papers/patents/academic reports, and a monograph on drugs
Eight FDA awards, over 100 drug-related reviews, leading and participating in the development of two industry generic guidelines and multiple specific drug guidelines
The honorary title of Novartis for Life “Novartis Leading Scientist”
